Our cell culture solutions are designed to support a seamless transition from process development to commercial manufacturing. Through Cell Culture Media Development (CCMD), the Rapid Response Program (RRP), and GMP manufacturing capabilities, we provide consistent media and feed solutions across development, pilot, and production scales.

Media can be supplied in powder or liquid formats for use across shake flasks, single use bioreactors, and stainless steel bioreactors. This flexibility helps support transitions across vessel formats and manufacturing scales while reducing scale up risk and helping teams move forward with greater confidence.

Teams typically transition from standard media to custom cell culture media when off the shelf formulations no longer meet their productivity, consistency, or product quality needs. As processes mature and move toward clinical or commercial manufacturing, tailored media formulations can be designed to better align with cell metabolism, process conditions, and manufacturing objectives.

This customization can help improve cell growth and productivity, enhance process consistency, and support critical product quality attributes such as glycosylation profiles, protein structure, and overall product performance. By aligning the media with the needs of the cell line and process, organizations can achieve more controlled and robust manufacturing outcomes at scale.

Cell culture feeds provide nutrients throughout cultivation to sustain viability and productivity. Feed composition and timing influence growth rates and byproduct formation. Optimized feeding helps improve yield and maintain process consistency.

Selecting CHO media involves evaluating cell line compatibility, productivity targets, and process format (batch or fed‑batch). Media composition affects growth, protein expression, and quality attributes. Choosing the right formulation helps maintain consistent performance across stages.

Density gradient media enable separation of cell populations based on density differences. This approach supports reproducible isolation of target cells from complex samples. In practice, it improves consistency in downstream applications such as cell therapy or analysis.

Cell line characteristics directly influence media requirements, feeding strategies, and culture conditions. The molecule being expressed can also affect cell metabolism, which means the same host cell may require different media and process conditions when producing a different product.

By aligning cell line and process development early, teams can identify the optimal media formulation and culture strategy for both the cell line and the molecule of interest. This integrated approach helps support cell growth, productivity, and product quality while establishing a scalable and reproducible manufacturing processes. Early collaboration can also reduce scale up risk and support more consistent performance during commercial manufacturing.